T-cell activation involves two phases, enabling a more precise immune response. This insight may boost cancer immunotherapy ...

Portage Biotech Inc.'s (PRTG) shares soared over 27% on Monday, marking their best session in more than three weeks, after ...

Portage Biotech stock jumped after new PORT-7 data showed enhanced immune response and plans advanced for combined A2A and ...

Shares of Portage Biotech climbed after the company reported confirmatory data for its PORT-7 treatment of mesothelioma, supporting plans for a human trial. The stock rose 21% to $10.23 Monday. Shares ...

AP Biosciences, a clinical-stage biopharmaceutical company dedicated to transforming cancer therapy through innovative bispecific antibodies, today announced the presentation of new preclinical data ...

The following is a summary of "ADORA2B promotes proliferation and migration in head and neck squamous cell carcinoma and is ...

Researchers identified a single protein in cyst nematodes that triggers dozens of the chemical signals called effectors that ...